Since his 2023 appointment to head the ASOC-MEZA region, Kumaraiah has moved away from the industry's impulse for quick wins. Instead, he advocates for a strategy rooted in patience and long-term trust. With product registration timelines varying from six months to six years depending on the country, the ability to plan strategically has become a core requirement of his leadership. He emphasizes that while Vygon maintains a consistent global standard for its medical devices, the delivery of these tools must be tailored to the specific socio-economic and regulatory conditions of each nation.
Central to this expansion is a shift toward a solution-oriented model. Kumaraiah notes that success is not merely about supply chain efficiency, but about building locally rooted training centers. By partnering with organizations like P&F Cares, Vygon aims to transform from a vendor into a clinical partner. This approach is particularly vital in neonatal and vascular care, where the barrier to better outcomes is often a lack of specialized training rather than a lack of technology. For Kumaraiah, who was recently honored with the title of Datuk, the next five years represent an opportunity to scale this impact while maintaining a firm commitment to ESG governance, ensuring that the company’s growth remains as much about saving lives as it is about market share.

Comments (0)
No comments yet. Be the first!